We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App




Fully Automated FIT Analyzer Designed for Labs with High Fecal Testing Volumes

By LabMedica International staff writers
Posted on 16 Jun 2022
Print article
Image: New SENTiFIT 800 analyzer for fecal immunochemical testing (Photo courtesy of Sentinel Diagnostics)
Image: New SENTiFIT 800 analyzer for fecal immunochemical testing (Photo courtesy of Sentinel Diagnostics)

Colorectal Cancer (CRC) is one of the most dangerous and lethal cancers. It represents the second leading cause of cancer related death in the western world with almost two million of new cases/year and 0.9 million deaths. If early diagnosed, CRC is curable in most of the cases, therefore most countries organize national or regional screenings to identify the cancers in their early stage, making the cure more efficient and thus considerably decreasing mortality. Those screening programs are testing millions of people every year and this creates new challenges in the practical organization of the laboratories. Now, a new high throughput analyzer for fecal immunochemical testing can meet the need for throughput, automation and accuracy in the most demanding situations.

Sentinel Diagnostics’ (Milan, Italy) new SENTiFIT 800 analyzer is a fully automated and high throughput system for fecal immunochemical test. The high-end system dedicated to fecal testing is able to process up to 550 tests per hour and one million tests every year with total automation and full traceability. It enables a reduction in hands-on time, better management of resources and decrease in manual errors. The system is fed by a dedicated sample loader (Rack Handler RH-150) that provides a steady flow of up to 250 samples to the analyzer unit.

The CE-marked SENTiFIT 800 Analyzer is compatible with the company’s FOB Gold line, the complete solution for the identification of occult blood in feces, and with its CALiaGold line of reagents for the quantification of fecal Calprotectin, the first-choice test to identify the presence of inflammation in the bowel.

"For almost 20 years, Sentinel Diagnostics has supported the fight against colorectal cancer with high quality FOB Gold test and analyzers," said Marco Buonaguidi, Head of Sales and Marketing at Sentinel Diagnostics. "The SENTiFIT 800 has been developed specifically for FIT screening centers and represents a step further in the direction to strengthen our commitment in the field of gastrointestinal diseases diagnosis."

Related Links:
Sentinel Diagnostics 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Pipet Controller
Stripettor Pro

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.